Haseki Training and Research Hospital
Sultangazi, Istanbul, 34340, Turkey (Türkiye)
NCT Number: NCT07035899
The effects of intravenous propofol administration for general anesthesia in cesarean deliveries on maternal and infant health will be evaluated in relation to maternal and umbilical cord blood propofol levels.
Looking for future studies?
Notify Me18 year–40 year
Female
Interventional
Not applicable
Sultangazi, Istanbul, 34340, Turkey (Türkiye)
After the ethics committee approval was obtained, volunteers who met the criteria for inclusion in the study were included in the study after obtaining their written permission. After the patients were taken to the operating room, IV catheterization was achieved after CTA, TA and sPO2 monitoring, and the patient was intubated 2 minutes after induction of propfol at 3 mg/kg and rocuronium at 0.6 mg/kg. After the baby was born, an intravenous blood sample was taken from the umbilical cord and the mother simultaneously. After the venous blood samples were obtained as 3 μL, the serum samples obtained by centrifugation as standard were portioned in equal volume to 500 μL Eppendorf tubes and stored at -80°C. After this pre-treatment, propofol was subjected to measurement tests with HPLC, and the collected data were added
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cesarean section was performed as routine surgical procedure
Time frame: The first 5 minutes of cesarean delivery
ng/ml
Haseki Training and Research Hospital
Other
Association of Maternal and Neonatal Umbilical Cord Blood Levels of Propofol Administered for Induction of General Anesthesia With Perinatal Findings in Gravidas Undergoing Cesarean Section
Acronym: PA-Perinatal-O
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04060667
Death, Female Urogenital Diseases and Pregnancy Complications
Mbarara, Uganda
View Trial DetailsNCT07719335
Female Urogenital Diseases and Pregnancy Complications, Pregnancy Complications
Banī Suwayf, Egypt
View Trial DetailsNCT07715422
Female Urogenital Diseases and Pregnancy Complications, Pregnancy Complications
Banī Suwayf, Beni Suweif Governorate, Egypt
View Trial DetailsNCT05576207
Anemia of Pregnancy, Birth Weight
Rangpur City, Bangladesh
View Trial Details